The Relationship between Nerve Growth Factor and Vitamin B12 as a Predictive Marker for Nerve Damage in Iraqi Patients with Systemic Lupus Erythematosus
Main Article Content
Abstract
Determination of serum nerve growth factor (NGF) and vitamin B12 in Iraqi female patients with systemic lupus erythematosus (SLE) and assessment of the effect of disease duration on the development of nerve damage. In addition, NGF may be a predictive marker for nerve damage in SEL patients. The current study included 130 individuals whose ages ranged from 18 to 48 years old, 100 of whom were female patients with SLE and 30 individuals as controls. Each patient was diagnosed after undergoing a thorough clinical evaluation backed by laboratory testing by a board-certified rheumatologist. The patients were classified according to the duration of disease into 15 patients with a disease duration of less than 3 months (G1), 29 patients with a disease duration of 1 year (G2), and 56 patients with a disease duration of more than one year (G3). This study showed a significant increase in serum NGF and a significant decrease in vitamin B12 levels in SLE patient groups when compared with control, as well as their level in SLE patients compared with control. Also, there was an essential negative correlation between NGF and vitamin B12 in SLE patients and controls. The present results found that the serum NGF levels in SLE patients considerably increased with the duration of the disease. Therefore, NGF may be a diagnostic and follow-up marker of the development of disease. In addition, the significant negative correlation between NGF and vitamin B12 indicates that SLE patients may be prone to nerve damage, and NGF may be a predictive biochemical marker for the development of nerve damage in SLE patients.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
licenseTerms
Publication Dates
Received
Accepted
Published Online First
References
Kwaben, V.B. Etiological Components and Patterns Contributing to the Development Of Systemic Lupus Erythematosus 2020. huskiecommons.lib.niu.edu https://huskiecommons.lib.niu.edu/studentengagement-honorscapstones/495,
Sirikonda, A.; Kolli, M.; Rao, M.R.; Srujana, S. A Study of Clinical Profile and Assessment of Disease Activity in Systemic Lupus Erythematosus Patients. International Archives of Integrated Medicine. 2019, 6(10), 22-27. http://iaimjournal.com/.
Fanouriakis, A.; Tziolos, N.; Bertsias, G.; Boumpas, D.T. Update on The Diagnosis and Management of Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases. 2021, (80), 14–25. https://doi.org/10.1136/annrheumdis-2020-218272.
Al-Hammamy, H.R.; Abd, K.H.; Khalil, I.A.; Mahdi, B.M. Human Leukocyte Antigens Assosiation with Systemic Lupus Arythematosus in Iraqi Patients. AL-Kindy College Medical Journal. 2012, 8(2), 84–88. https://www.jkmc.uobaghdad.edu.iq.
McMurray, R.W.; May, W. Sex Hormones and Systemic Lupus Erythematosus: Review and Meta-Analysis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology. 2003, 48, 2100–2110. https://doi.org/10.1002/art.11105.
Gergianaki, I.; Fanouriakis, A.; Repa, A.; Tzanakakis, M.; Adamichou, C.; Pompieri, A.; Spirou, G.; Bertsias, A.; Kabouraki, E.; Tzanakis, I. Epidemiology and Burden of Systemic Lupus Erythematosus in A Southern European Population: Data from the Community-Based Lupus Registry of Crete, Greece. Annals of the Rheumatic Diseases. 2017, 76(12), 1992–2000. https://doi.org/10.1136/annrheumdis-2017-211206.
Dahham, Z.M.; Haddad, N.I.A. Circulating levels of interferon regulatory factor-5 correlates with disease activity in systemic lupus erythematosus iraqi patients. Journal of Contemporary Medical Sciences. 2022, 8(6), 388–394. 7a90c67557779d5d (iasj.net).
Barcia-Sixto, L.; Isenberg, D. Systemic Lupus Erythematosus: Causes and Manifestations. Trends Urol. Men’s Heal 2020, 11, 26–29. https://doi.org/10.1002/tre.732.
Saha, B.K.; Bonnier, A.; Chenna, P.; Milman, N.T. Prevalence of Autoantibodies in Pediatric Patients with Idiopathic Pulmonary Hemosiderosis: A Scoping Review of the Literature in the Period 1980–2021. Clin Rheumatol 2022, 41(4), 977–990. https://doi.org/10.1007/s10067-021-06029-3.
Barker, P.A.; Mantyh, P.; Arendt-Nielsen, L.; Viktrup, L.; Tive, L. Nerve Growth Factor Signaling and its Contribution To Pain. Journal of Pain Research. 2020, 1, 1223–1241. https://doi.org/10.1148/rg.210045.
Rusher, D.R.; Pawlak, R.A Review of 89 Published Case Studies of Vitamin B12 Deficiency. J Hum Nutr Food Sci. 2013, 1, 1008. https://www.jscimedcentral.com/public/assets/articles/nutrition-1-1008.pdf.
Stabler, S.P.; Korson, M.; Jethva, R.; Allen, R.H.; Kraus, J.P.; Spector, E.B.; Wagner, C.; Mudd, S.H. Metabolic Profiling of Total Homocysteine and Related Compounds in Hyperhomocysteinemia: Utility and Limitations in Diagnosing the Cause of Puzzling Thrombophilia in a Family. JIMD Reports 2013, 11(2013), 149–163. https://doi.org/10.1007/8904_2013_235.
Weckerle, C.E.; Niewold, T.B. The Unexplained Female Predominance of Systemic Lupus Erythematosus: Clues From Genetic and Cytokine Studies. Clinical reviews in allergy & immunology. 2011, 40(1), 42-49. https://doi.org/10.1007/s12016-009-8192-4.
Leuchten, N.; Hoyer, A.; Brinks, R.; Schoels, M.; Schneider, M.; Smolen, J.; Johnson, S.R.; Daikh, D.; Doerner, T.; Aringer, M. Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic Data. Arthritis Care Res. (Hoboken) 2018, 70(3), 428–438. https://doi.org/10.1002/acr.23292.
Noori, A.S.; Jawad, A.M.; Jassim, N.A.; Gorial, F.I. Prevalence of Antiphospholipid Antibodies in Sample of Iraqi Patients with Systemic Lupus Erythematosus: A Cross Sectional Study. American Journal of Clinical Medicine Research. 2013, 1(4), 61–64. https://doi.org/10.12691/ajcmr-1-4-4.
Alaanzy, M.T.; Alsaffar, J.M.J.; Bari, A.A. Evaluate the Correlation between Antioxidant Capacity and Interferon? Level with the Disease Activity of Sle Patients in Iraqi Woman. Indian J Public Heal Res Dev 2020, 11, 1278–1282. https://doi.org/10.37506/v11/i1/2020/ijphrd/194018 1278.
Fu, S.M.; Dai, C.; Zhao, Z.; Gaskin, F. Anti-DsDNA Antibodies are One of the Many Autoantibodies in Systemic Lupus Erythematosus. F1000Research 2015, 4, 939. https://doi.org/12688/f1000research.6875.1.
Karrar, S.; Graham, D.S.C. Abnormal B Cell Development in Systemic Lupus Erythematosus: What the Genetics Tell Us. Arthritis Rheumatol. (Hoboken, Nj) 2018, 70(4), 496. https://doi.org/10.1002/art.40396.
Celhar, T.; Fairhurst, A.-M. Toll-like Receptors in Systemic Lupus Erythematosus: Potential for Personalized Treatment. Front. Pharmacol 2014, 5, 265. https://doi.org/10.3389/fphar.2014.00265.
Chen, J.; Zhang, H.; Chen, P.; Lin, Q.; Zhu, X.; Zhang, L.; Xue, X. Correlation Between Systemic Lupus Erythematosus and Cytomegalovirus Infection Detected by Different Methods. Clin. Rheumatol 2015, 34(4), 691–698. https://doi.org/10.1007/s10067-015-2868-3.
Molano-González, N.; Rojas, M.; Monsalve, D.M.; Pacheco, Y.; Acosta-Ampudia, Y.; Rodríguez, Y.; Rodríguez-Jimenez, M.; Ramírez-Santana, C.; Anaya, J.-M. Cluster Analysis of Autoimmune Rheumatic Diseases Based on Autoantibodies. New Insights for Polyautoimmunity. J. Autoimmun. 2019, 98, 24–32. https://doi.org/10.1016/j.jaut.2018.11.002.
González, L.A.; Santamaría-Alza, Y.; Alarcón, G.S. Organ Damage in Systemic Lupus Erythematosus. Revista Colombiana de Reumatología. 2021, 28(1), 66–81. https://doi.org/10.1016/j.rcreu.2021.01.008.
Imam, M.H.; Koriem, H.K.; Hassan, M.M.; El-Hadidi, A.S.; Ibrahim, N.A. Pattern of peripheral Neuropathy in Systemic Lupus Erythematosus: Clinical, Electrophysiological, and Laboratory Properties and their Association with Disease Activity. Egypt Rheumatol Rehabil 2019, 46, 285–298. https://doi.org/10.4103/err.err_28_19.
Ben Salem, T.; Belfeki, N.; Lamloum, M. Peripheral Neuropathies in Patients with Systemic Lupus Erythematosus. J Neurol Neurosci. 2016, 7, S3. https://doi.org/10.21767/2171-6625.1000127
Ramos-Casals, M.; Nardi, N.; Lagrutta, M.; Brito-Zerón, P.; Bové, A.; Delgado, G.; Cervera, R.; Ingelmo, M.; Font, J. Vasculitis in Systemic Lupus Erythematosus: Prevalence and Clinical Characteristics in 670 Patients. Medicine (Baltimore). 2006, 85(2), 95–104. https://doi.org/10.1097/01.md.0000216817.35937.70.
Bortoluzzi, A.; Silvagni, E.; Furini, F.; Piga, M.; Govoni, M. Peripheral Nervous System Involvement in Systemic Lupus Erythematosus: A review of the Evidence. Clinical and Experimental Rheumatology 2019, 37(1), 146–155. https://www.ncbi.nlm.nih.gov/pubmed/29846158.
Moisset, X.; Bouhassira, D. Brain Imaging of Neuropathic Pain. Neuroimage 2007, 37(1), S80–S88. https://doi.org/10.1016/j.neuroimage.2007.03.054
Seidel, M.F.; Herguijuela, M.; Forkert, R.; Otten, U. Nerve Growth Factor in Rheumatic Diseases. In Proceedings of The Seminars in Arthritis and Rheumatism. Elsevier 2010, 40(2),109–126. https://doi.org/10.1016/j.semarthrit.2009.03.002.
Evans, L.J.; Loescher, A.R.; Boissonade, F.M.; Whawell, S.A.; Robinson, P.P.; Andrew, D. Temporal Mismatch between Pain Behaviour, Skin Nerve Growth Factor and Intra-Epidermal Nerve Fibre Density in Trigeminal Neuropathic Pain. BMC Neuroscience. 2014, 15, 1–15. https://doi.org/10.1186/1471-2202-15-1.
Wieske, L.; Smyth, D.; Lunn, M.P.; Eftimov, F.; Teunissen, C.E. Fluid Biomarkers for Monitoring Structural Changes in Polyneuropathies: Their Use in Clinical Practice and Trials. Neurotherapeutics. 2021, 18(4), 2351–2367. https://doi.org/10.1007/s13311-021-01136-0.
McKelvey, L.; Shorten, G.D.; O’Keeffe, G.W. Nerve Growth Factor‐Mediated Regulation of Pain Signalling and Proposed New Intervention Strategies in Clinical Pain Management. J Neurochem 2013, 124(3), 276–289. https://doi.org/10.1111/jnc.12093.
Wang, D.; Zhang, P.; Li, Z.; Liu, Y. Effects of Mecobalamin On Bax And Bcl-2 in Neurons after Peripheral Nerve Injury. Zhonghua lao Dong wei Sheng zhi ye Bing za zhi= Zhonghua Laodong Weisheng Zhiyebing Zazhi= Chinese journal of industrial hygiene and occupational diseases. 2015, 33(11), 841–843. cites:27212931_MED - Search results - Europe PMC.
Keenan, R.T.; Swearingen, C.J.; Yazici, Y. Erythrocyte Sedimentation Rate and C-Reactive Protein Levels are Poorly Correlated with Clinical Measures of Disease Activity in Rheumatoid Arthritis, Systemic Lupus Erythematosus and Osteoarthritis Patients. Clin Exp Rheumatol 2008, 26(5), 814. PMID: 19032813.
Aringer, M. Inflammatory Markers in Systemic Lupus Erythematosus. Journal of Autoimmunity 2020, 110, 102374. https://doi.org/10.1016/j.jaut.2019.102374.
Aringer, M.; Costenbader, K.; Daikh, D.; Brinks, R.; Mosca, M.; Ramsey-Goldman, R.; Smolen, J.S.; Wofsy, D.; Boumpas, D.T.; Kamen, D.L.; Jayne, D.; Cervera, R.; Costedoat-Chalumeau, N.; Diamond , B.; Gladman, D.D.; Hahn, B.; Hiepe, F.; Jacobsen, S.; Khanna, D.; Lerstrøm, K.; Massarotti, E.; McCune, J.; Ruiz-Irastorza, G.; Sanchez-Guerrero, J.; Schneider, M.; Urowitz, M.; Bertsias, G.; Hoyer, B.F.; Leuchten , N.; Tani, Ch.; Tedeschi, S.K.; Touma, Z.; Schmajuk, G.; Anic, B.; Assan, F.; Chan, T.M. Clarke, A.E.; Crow, MK. Czirják, L.; Doria, A.; Graninger, W.; Halda-Kiss, B.; Hasni, S,; Izmirly, P.M.; Jung, M.; Kumánovics, G.; Mariette, X.; Padjen, I.; Pego-Reigosa, J.M.; Romero-Diaz, J.; Fernández, I.R-F.; Seror, G.H.; Stummvoll , R.; ] Tanaka, Y.; Tektonidou, M.G.; Vasconcelos, C.; Vital, E.M.; Wallace, D.J.; Yavuz, S.; Meroni, P.L.; Fritzler, M.J.; Naden, R.; Dörner, T.; Johnson, R.S. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis & rheumatology. 2019, 71(9), 1400-1412. https://doi.org/10.1002/art.40930.
Curtiss, P.; Liebman, T.; Khorolsky, C.; Brinster, N.; Beasley, J.; Sicco, K. Lo Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: An Emerging Overlap Syndrome with Cutaneous Manifestations. JAAD Case Reports 2018, 4(5),493-496 https://doi.org/10.1016/j.jdcr.2018.01.021.
Voulgarelis, M.; Kokori, S.I.; Ioannidis, J.P.; Tzioufas, A.G.; Kyriaki, D.; Moutsopoulos, H.M. Anaemia in Systemic Lupus Erythematosus: Aetiological Profile and the Role of Erythropoietin. Annals of the Rheumatic Diseases. 2000, 59(3), 217–222. https://doi.org/10.1136/ard.59.3.217.
Sultan, S.M.; Begum, S.; Isenberg, D.A. Prevalence, Patterns Of Disease and Outcome in Patients with Systemic Lupus Erythematosus Who Develop Severe Haematological Problems. Rheumatology 2003, 42(2), 230-234 . https://doi.org/10.1093/rheumatology/keg069.
Aleem, A.; Al Arfaj, A.S.; khalil, N.; Alarfaj, H. Haematological Abnormalities in Systemic Lupus Erythematosus. Acta Reumatol Port 2014, 39(3), 236–241. https://doi.org/10. 1136/ annrheumdis- 2020- 218272.